Actively Recruiting
Covid-19 in Hematological Malignancies
Led by Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne · Updated on 2025-05-29
3000
Participants Needed
6
Research Sites
304 weeks
Total Duration
On this page
Sponsors
S
Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne
Lead Sponsor
E
European Hematology Association
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall purpose of this project is to better understand the epidemiology of COVID-19 in patients with hematological malignancies (including hematopoietic stem cell transplant recipients) in the different European Countries. The results obtained will allow us to better know the prevalence of this complication in the different categories of patients with hematological malignancies (HMs). In order to attain the objectives previously described we will develop a multicentre, international, observational, retrospective and prospective study of consecutive cases of COVID-19 among HMs. There will be a clinical follow-up of the patients included in this study to observe the survival rate. Data collected form this study will be evaluated with a descriptive analysis.
CONDITIONS
Official Title
Covid-19 in Hematological Malignancies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age equal to or greater than 18 years of age.
- History of hematological malignancies (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma, chronic myeloprolipherative disorders) at any stage/status.
- Active hematological malignancies at any stage/status.
- Diagnosis of hematological malignancy (acute leukemias, myelodysplastic syndromes, myeloproliferative neoplasms, lymphomas, myeloma, chronic myeloprolipherative disorders) at any stage/status.
- SARS-CoV-2 positive test (nasopharyngeal, BAL, fecal), documented by Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panels.
You will not qualify if you...
- Hematological diseases, other than hematological malignancies.
- Not tested positive for SARS-CoV-2
- Patients "off therapy" for more than 5 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
ASST-Spedali Civili
Brescia, Italy
Actively Recruiting
2
AOU Policlinico Federico II
Naples, Italy
Actively Recruiting
3
Fondazione Policlinico A. Gemelli IRCCS
Rome, Italy
Actively Recruiting
4
Istituto Nazionale Tumori Regina Elena IFO
Rome, Italy
Actively Recruiting
5
Osp. di Circolo-Fondazione Macchi
Varese, Italy
Actively Recruiting
6
AOUI Verona
Verona, Italy
Actively Recruiting
Research Team
L
livio pagano, Prof
CONTACT
J
Jon Salmanton Garcia, Dr
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here